Sickle Cell Disease

The underutilization of disease-modifying therapy by people with sickle cell disease is “persistent and alarming,” according to an analysis of real-world data.

SAN DIEGO — Lauren E. Merz, MD, MSc, can still feel both the relief and anger two parents expressed during her first year of medical school at University of Michigan.

Sickle cell trait does not cause individuals to die of physical exertion or heat-related injuries without rhabdomyolysis, according to a findings of a systematic literature review.

KOLOA, Hawaii — In this Healio Video Perspective from Retina 2025, Adrienne W. Scott, MD, of Johns Hopkins University School of Medicine, discusses her research in sickle cell disease and sickle cell retinopathy.

People with cancer should receive “current, accurate and digestible” information that allows them to be “active stakeholders” in their cancer journey, according to NCI Director W. Kimryn Rathmell, MD, PhD, MMHC.

An increasing number of gene therapies correct genetic disorders, including hemoglobinopathies.

In this video, Ronak Mistry, DO, discusses the results of a study presented at ASH Annual Meeting that examined the use of hydroxyurea in patients with hemoglobin SC disease.

In this special crossover episode of Oncology Overdrive, we bring you Healio coverage from the ASH Annual Meeting and Exhibition, as well as Healio’s top headlines from the meeting.

SAN DIEGO — Psychological and neurocognitive screening may help monitor mental and physical health among people with sickle cell disease, according to a speaker at ASH Annual Meeting and Exposition.

American Society of Hematology presented Advocacy Awards to two individuals at this year’s ASH Annual Meeting.